CLINICAL_TRIALS
withdrawal
· 2024-05-03
Clinical Trial Update: Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission [Phase 1]
Summary
A Phase 1 clinical trial evaluating neutralizing antibodies and vaccination to induce HIV remission has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: HIV-1-infection | Phase 1 | Status: WITHDRAWN